CENTRE OF EXCELLENCE IN
COMPLEX DISEASE GENETICS

 

 
   
   
         

Group Jalanko

 

  
           

The research group is devoted to developing models to study molecular mechanisms behind neurodegeneration. Our previous work has concentrated on utilization of cell and mouse models to analyze disease mechanisms behind lysosomal storage diseases affecting the central nervous system: Aspartylglucosaminuria (AGU) and neuronal ceroid lipofuscinoses (NCL), including infantile, variant late infantile and juvenile diseases (INCL, vLINCLFin, JNCL). More recently, we have been able to reveal the first functional properties of the NCL-proteins and this work is being continued.  NCL involves mutations in ion channel – transporter type of membrane proteins, offering synergy with the functional analyses of epilepsy.  The NCL disorders are monogenic but as a group can be utilized as a model to tackle complex functional mechanisms and gene interplay. We have generated and initially characterized knock-out mouse models for NCL. These mouse models will be utlilized for novel genome-wide expression analyses, brain imaging and biocomputing, to reveal mechanisms in CNS diseases. The group will further be responsible for the operations of the mouse core of CECDG. The group shares significant research interest with the group Peltonen, to utilize genome-wide analysis methods for the analysis of gene function and Lehesjoki, to analyze molecular mechanisms of neurodegeneration.

     
 
RESEARCH GROUP
 

Jalanko Anu, PhD, Director of Dept.

 
POST-DOCTORAL SCIENTISTS:
Kopra Outi (50%)
Kyttälä Aija
 
PhD STUDENTS:
Ahtiainen Laura
Lyly Annina
von Schantz-Fant Carina
Yliannala Kristina
 
UNDERGRADUATE STUDENTS:
Maaranen Elina
 
STAFF:
Antila Kaija
Kaiharju Essi
Manninen Tuula
Toivola Auli
 
 
 
 
 
 
 
 
 
       
MOST IMPORTANT PUBLICATIONS:
 

Lehtovirta, M., Kyttälä, A., Eskelinen, E-L., Hess, M., Heinonen, O., Jalanko, A. Palmitoyl protein thioesterase (PPT) localizes into synaptosomes and synaptic vesicles in neurons: Implications for infantile neuronal ceroid lipofuscinosis (INCL). Hum. Mol. Genet., 10:1:69-75, 2001.

 

Luiro, K., Kopra, O., Lehtovirta, M., Jalanko, A. CLN3 protein is targeted to neuronal synapses but excluded from synaptic vesicles: New clues to Batten disease. Hum. Mol. Genet. 10:2123-2131, 2001.

 

Kopra O, Vesa J, von Schantz C,  Manninen T, Minye H, Fabritius A-L, Rapola J, vanDiggelen O, Saarela J, Jalanko A, Peltonen L. A mouse model for Finnish variant late infantile neuronal ceroid lipofuscinosis, CLN5, reveals neuropathology associated with early aging. Hum. Mol. Genet. 13:2893-2906, 2004.

 

Luiro K, Yliannala K, Ahtiainen L, Maunu H, Järvelä I, Kyttälä A,  Jalanko A Interconnections of CLN3, Hook1 and Rab proteins link Batten disease to defects in the endocytic pathway. Hum. Mol. Genet.13: 3017-3027, 2004.

 

Jalanko A, Vesa J, Manninen T, von Schantz C, Minye H, Fabritius A-L, Salonen T, Rapola J, Gentile M, Kopra O, Peltonen L Mice with Ppt1∆ex4 mutation replicate the INCL phenotype and show an inflammation associated loss of interneurons. Neurobiol. Dis. 18:226-41, 2005.